Joshua Turse

Experience

• 

  Magainin Pharmaceuticals/Genaera Corporation

  Jan 1996 - Jan 1998

  Research Assistant

  • Analyzed multiple magainin- and aminosterol-based compounds by HPLC and identified the peptides with MALDI-TOF• Developed methods for LC, LC/MS, and MALDI-TOF analysis of magainin and aminosterol-based compounds• Co-authored section of New Drug Application Chemistry Manufacturing and Control (NDA/CMC)

• 

  Texas A&M University

  Jan 1998 - Jan 2005

  Graduate Assistant - Research

  Performed research under NIH Grant, Improved Brucella Vaccine Strains, to develop new understanding of brucellosis, a significant zoonosis and bioweapon.• Defined naturally occurring rough, cytotoxic mutants of Category B, biological safety level 3 (BSL3) pathogen, Brucella melitensis, a human and animal health threat to better understand host invasion. Resulted in 3 peer-reviewed publications, 4 national conference presentations.• Specialty training in handling, administration, and maintenance of Category B, biological safety level 3 (BSL3), select agents and select agent facilities, trained 2 junior graduate students, 2 undergraduate students. Also obtained DOJ/CDC Select Agent Clearance. Show less

• 

  Washington State University

  Sept 2007 - May 2009

  Adjunct Faculty Member

  Designed graduate course, developed curriculum for delivery of classroom and online coursework via multimedia distance learning between Washington State University TriCities and Pullman campuses.• Prepared and delivered lectures to graduate students in seminar-style class on proteomics, beginning with genomics as foundation. Over 2 years taught approximately 20 graduate students.• Integrated research at Pacific Northwest National Laboratory into daily classroom activities to achieve inquiry-based classroom. Show less

• 

  Washington State University

  Oct 2009 - Dec 2013

  Associate in Research

  Designed, organized, directed and performed applied microbiology experiments in naïve and vaccinated cattle to assess T cell response to infection by Anaplasma marginale, tick borne pathogen. • Engineered, purified 18 recombinant proteins including 2 chimeric outer membrane proteins for use as vaccine candidates.• Established collaboration between Washington State University and Pacific Northwest National Laboratory for solving Dermacentor andersoni (Rocky Mountain wood tick) salivary gland proteome (published July 2014) in order to extend understanding of disease transmission between ticks and hosts.• Trained and supervised 1 post-baccalaureate, 4 graduate students, 5 veterinary students in all aspects of biological safety, molecular biology required for animal experiments and safe conduct of research in a biological safety level 2 (BSL2) space.• Designed and performed experiments with 3 cattle herds of 10-30 animals in collaboration with academic and corporate researchers including correct application of Institutional Animal Care and Use Committee (IACUC) guidelines and administration of private grant opportunities.• Produced 4 peer-reviewed papers; oral presentation at the American Society of Rickettsiology 25th meeting. Show less

• 

  Consulting Scientist

  Jan 2014 - now

  Free-lance consultant, technical writer

  I provide contract technical writing and consulting for private, small science firms and biosafety consulting. As a consultant I can provide general guidelines on work with bloodborne pathogens and infectious agents to researchers to establish for safe work practices. This includes risk assessment, hazard identification, nucleic acid work and regulatory items relevant to risk assessment such as the NIH Guidelines, CDC BMBL, select agents, and animal biosafety. I provide technical writing and editing services for infectious disease, vaccine, and systems biology centered work. Show less

• 

  Chapman University

  Apr 2015 - Nov 2015

  Laboratory Safety Administrator

  In this Chapman University, Rinker Health Sciences campus-based position, I was the principle Environmental Health & Safety (EH&S) professional responsible for supporting the success of RHSC laboratory safety management. Reporting to the Director of Risk Management, I served in three key areas of responsibility. First, as an EH&S safety officer, my duties involved assured compliance with all matters of health and safety at the Rinker campus, with an emphasis on laboratory safety for both the research and teaching labs. In addition, I served as a resource to RHSC faculty, staff and researchers in an effort to support their key objectives, principally as relate to research activities. This includes the Pharmacy and Physical Therapy programs, Physician Assistant program, and other programs that will operate from that campus. Additionally I serve as the Chapman University Biosafety Officer, and support the activities of the Institutional Biosafety Committee (IBC), Science Safety Committee (SSC), and various subcommittees that support the colleges of science of the University. I also serve as the key EH&S representative on the Institutional Animal Care and Use Committee (IACUC) as well as the Institutional Review Board (IRB.) Show less

• 

  Cornell University

  Dec 2015 - now

  Lead the integration and oversight of biosafety, laboratory safety, and radiation safety programs across Cornell’s Ithaca, Geneva Agritech, and NYC Tech campuses.Manage multidisciplinary teams ensuring compliance with federal, state, and institutional regulations.Provide strategic leadership in risk management for high-risk Select Agents, laboratory safety, and emerging technologies.Oversee safety-related operations for teaching, research, and diagnostic laboratories, focusing on proactive risk assessment and mitigation strategies. Show less

  • Director of Research Safety

    Dec 2024 - now

  • Biosafety Officer

    Nov 2019 - now

  • Associate Biosafety Officer at Cornell University

    Apr 2018 - Nov 2019

  • Biosafety Specialist

    Dec 2015 - Apr 2018